"Mount Carmel St. Ann's has always been the sole, full-service inpatient hospital in northeast central Ohio. But thanks to a recent expansion, it's transformed into a regional medical center with a long list of patient-centered facilities and services."

During the past decade, Saint Ann's Hospital conducted 131 clinical trials. In the 10-year time frame, 131 clinical trials started and 112 clinical trials were completed, i.e. on average, 85.5% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 66 clinical trials were completed. i.e. 124.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Ann's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 127 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "GOG Foundation" with 12 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Ann's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Saint Ann's Hospital" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Breast Cancer AJCC v6 and v7" (10 trials) and "Recurrent Fallopian Tube Carcinoma" (8 trials). Many other conditions were trialed in "Saint Ann's Hospital" in a lesser frequency.

Most popular intervention types in "Saint Ann's Hospital" are "Drug" (186 trials), "Other" (155 trials), "Biological" (101 trials), "Procedure" (55 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (85 trials), "Quality-of-Life Assessment" (70 trials), "Questionnaire Administration" (39 trials), "Paclitaxel" (32 trials) and "Carboplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Saint Ann's Hospital" are 171 trials for "All" genders, 56 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Ann's Hospital". undefined are not yet recruiting, 50 are recruiting, 112 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Saint Ann's Hospital, 2 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Ann's Hospital, 9 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 121 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".